1
|
Castro-Falcón G, Straetener J, Bornikoel J, Reimer D, Purdy TN, Berscheid A, Schempp FM, Liu DY, Linington RG, Brötz-Oesterhelt H, Hughes CC. Antibacterial Marinopyrroles and Pseudilins Act as Protonophores. ACS Chem Biol 2024; 19:743-752. [PMID: 38377384 PMCID: PMC10949930 DOI: 10.1021/acschembio.3c00773] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2023] [Accepted: 12/27/2023] [Indexed: 02/22/2024]
Abstract
Elucidating the mechanism of action (MoA) of antibacterial natural products is crucial to evaluating their potential as novel antibiotics. Marinopyrroles, pentachloropseudilin, and pentabromopseudilin are densely halogenated, hybrid pyrrole-phenol natural products with potent activity against Gram-positive bacterial pathogens like Staphylococcus aureus. However, the exact way they exert this antibacterial activity has not been established. In this study, we explore their structure-activity relationship, determine their spatial location in bacterial cells, and investigate their MoA. We show that the natural products share a common MoA based on membrane depolarization and dissipation of the proton motive force (PMF) that is essential for cell viability. The compounds show potent protonophore activity but do not appear to destroy the integrity of the cytoplasmic membrane via the formation of larger pores or interfere with the stability of the peptidoglycan sacculus. Thus, our current model for the antibacterial MoA of marinopyrrole, pentachloropseudilin, and pentabromopseudilin stipulates that the acidic compounds insert into the membrane and transport protons inside the cell. This MoA may explain many of the deleterious biological effects in mammalian cells, plants, phytoplankton, viruses, and protozoans that have been reported for these compounds.
Collapse
Affiliation(s)
- Gabriel Castro-Falcón
- Center
for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California, San Diego, California 92093, United States
| | - Jan Straetener
- Department
of Microbial Bioactive Compounds, Interfaculty Institute of Microbiology
and Infection Medicine, University of Tübingen, Tübingen 72076, Germany
| | - Jan Bornikoel
- Department
of Microbial Bioactive Compounds, Interfaculty Institute of Microbiology
and Infection Medicine, University of Tübingen, Tübingen 72076, Germany
| | - Daniela Reimer
- Center
for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California, San Diego, California 92093, United States
| | - Trevor N. Purdy
- Center
for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California, San Diego, California 92093, United States
| | - Anne Berscheid
- Department
of Microbial Bioactive Compounds, Interfaculty Institute of Microbiology
and Infection Medicine, University of Tübingen, Tübingen 72076, Germany
| | - Florence M. Schempp
- Center
for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California, San Diego, California 92093, United States
| | - Dennis Y. Liu
- Department
of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada
| | - Roger G. Linington
- Department
of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada
| | - Heike Brötz-Oesterhelt
- Department
of Microbial Bioactive Compounds, Interfaculty Institute of Microbiology
and Infection Medicine, University of Tübingen, Tübingen 72076, Germany
- Cluster
of Excellence EXC 2124: Controlling Microbes to Fight Infection, University of Tübingen, Tübingen 72076, Germany
- German
Center for Infection Research, Partner Site Tübingen, Tübingen 72076, Germany
| | - Chambers C. Hughes
- Center
for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California, San Diego, California 92093, United States
- Department
of Microbial Bioactive Compounds, Interfaculty Institute of Microbiology
and Infection Medicine, University of Tübingen, Tübingen 72076, Germany
- Cluster
of Excellence EXC 2124: Controlling Microbes to Fight Infection, University of Tübingen, Tübingen 72076, Germany
- German
Center for Infection Research, Partner Site Tübingen, Tübingen 72076, Germany
| |
Collapse
|
2
|
Xiao Y, Yang J, Zou L, Wu P, Li W, Yan Y, Li Y, Li S, Song H, Zhong W, Qin Y. Synthesis of 10,10′-bis(trifluoromethyl) marinopyrrole A derivatives and evaluation of their antiviral activities in vitro. Eur J Med Chem 2022; 238:114436. [DOI: 10.1016/j.ejmech.2022.114436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2022] [Revised: 04/28/2022] [Accepted: 04/29/2022] [Indexed: 11/26/2022]
|
3
|
Xu Z, Xian N, Chen H, Deng G, Huang H. Cu‐Catalyzed
Cascade Cyclization of Ketoxime Acetates and Alkynals Enabling Synthesis of Acylpyrroles. CHINESE J CHEM 2021. [DOI: 10.1002/cjoc.202000660] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Affiliation(s)
- Zhenhua Xu
- Key Laboratory for Green Organic Synthesis and Application of Hunan Province, Key Laboratory of Environmentally Friendly Chemistry and Application of Ministry of Education, College of Chemistry, Xiangtan University Xiangtan Hunan 411105 China
| | - Ning Xian
- Key Laboratory for Green Organic Synthesis and Application of Hunan Province, Key Laboratory of Environmentally Friendly Chemistry and Application of Ministry of Education, College of Chemistry, Xiangtan University Xiangtan Hunan 411105 China
| | - Hongbiao Chen
- Key Laboratory for Green Organic Synthesis and Application of Hunan Province, Key Laboratory of Environmentally Friendly Chemistry and Application of Ministry of Education, College of Chemistry, Xiangtan University Xiangtan Hunan 411105 China
| | - Guo‐Jun Deng
- Key Laboratory for Green Organic Synthesis and Application of Hunan Province, Key Laboratory of Environmentally Friendly Chemistry and Application of Ministry of Education, College of Chemistry, Xiangtan University Xiangtan Hunan 411105 China
| | - Huawen Huang
- Key Laboratory for Green Organic Synthesis and Application of Hunan Province, Key Laboratory of Environmentally Friendly Chemistry and Application of Ministry of Education, College of Chemistry, Xiangtan University Xiangtan Hunan 411105 China
| |
Collapse
|
4
|
Patel A, Shah H, Shah U, Bambharoliya T, Patel M, Panchal I, Parikh V, Nagani A, Patel H, Vaghasiya J, Solanki N, Patel S, Shah A, Parmar G. A Review on the Synthetic Approach of Marinopyrroles: A Natural Antitumor Agent from the Ocean. LETT ORG CHEM 2021. [DOI: 10.2174/1570178617999200718004012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Natural products play an important role in various drug discovery and development approaches.
They are known to be the rich resources for the identification of new chemical entities
(NCEs) intended to treat various diseases. Many drugs have been discovered and developed from natural
sources. Indeed, collaborative efforts involving biologists as well as organic, medicinal, and phytochemists
usually facilitate the identification of potent NCEs derived from natural sources. Over the past
20 years, more than 50% of NCEs have been derived either from marine sources or synthetic/
semisynthetic derivatives of natural products. Indeed, many drug molecules have been designed by
considering natural products as the starting scaffold. The first bis-pyrrole alkaloid derivative of
marinopyrroles was obtained from the marine-derived streptomycete species. In the laboratory, it can
be synthesized via Clauson-Kaas and Friedel-Crafts arylation as well as copper-mediated N-arylation
process under microwave irradiation. The marinopyrrole A (±)-28 was discovered to overcome resistance
against human cancer cells by antagonizing B-cell lymphoma extra-large (Bcl-xL) and induced
myeloid leukaemia cell (Mcl-1). In this review, we elaborated on various synthetic pathways of
marinopyrroles possessing anti-cancer potential, which could encourage researchers to discover promising
anti-tumor agents.
Collapse
Affiliation(s)
- Ashish Patel
- Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, Ta. Petlad, Dist. Anand, Gujarat,India
| | - Hirak Shah
- Parul Institute of Pharmacy, Parul University, Vadodara, Gujarat,India
| | - Umang Shah
- Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, Ta. Petlad, Dist. Anand, Gujarat,India
| | | | - Mehul Patel
- Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, Ta. Petlad, Dist. Anand, Gujarat,India
| | - Ishan Panchal
- Parul Institute of Pharmacy, Parul University, Vadodara, Gujarat,India
| | - Vruti Parikh
- Parul Institute of Pharmacy, Parul University, Vadodara, Gujarat,India
| | - Afzal Nagani
- Parul Institute of Pharmacy, Parul University, Vadodara, Gujarat,India
| | - Harnisha Patel
- Parul Institute of Pharmacy, Parul University, Vadodara, Gujarat,India
| | | | - Nilay Solanki
- Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, Ta. Petlad, Dist. Anand, Gujarat,India
| | - Swayamprakash Patel
- Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, Ta. Petlad, Dist. Anand, Gujarat,India
| | - Ashish Shah
- Department of Pharmacy, Sumandeep Vidhyapeeth, Vadodara, Gujarat,India
| | - Ghanshyam Parmar
- Department of Pharmacy, Sumandeep Vidhyapeeth, Vadodara, Gujarat,India
| |
Collapse
|
5
|
Singh N, Singh S, Kohli S, Singh A, Asiki H, Rathee G, Chandra R, Anderson EA. Recent progress in the total synthesis of pyrrole-containing natural products (2011–2020). Org Chem Front 2021. [DOI: 10.1039/d0qo01574a] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
This review discusses total syntheses of pyrrole-containing natural products over the last ten years, highlighting recent advances in the chemistry of pyrroles in the context of their innate reactivity, and their preparation in complex settings.
Collapse
Affiliation(s)
- Nidhi Singh
- Department of Chemistry, University of Delhi, Delhi 110007, India
| | - Snigdha Singh
- Department of Chemistry, University of Delhi, Delhi 110007, India
| | - Sahil Kohli
- Department of Chemistry, University of Delhi, Delhi 110007, India
| | - Aarushi Singh
- Department of Chemistry, University of Delhi, Delhi 110007, India
| | - Hannah Asiki
- Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK
| | - Garima Rathee
- Department of Chemistry, University of Delhi, Delhi 110007, India
| | - Ramesh Chandra
- Department of Chemistry, University of Delhi, Delhi 110007, India
- Dr B. R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi 110007, India
| | - Edward A. Anderson
- Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK
| |
Collapse
|
6
|
Bernatchez JA, Tran LT, Li J, Luan Y, Siqueira-Neto JL, Li R. Drugs for the Treatment of Zika Virus Infection. J Med Chem 2019; 63:470-489. [PMID: 31549836 DOI: 10.1021/acs.jmedchem.9b00775] [Citation(s) in RCA: 51] [Impact Index Per Article: 10.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
Zika virus is an emerging flavivirus that causes the neurodevelopmental congenital Zika syndrome and that has been linked to the neuroinflammatory Guillain-Barré syndrome. The absence of a vaccine or a clinically approved drug to treat the disease combined with the likelihood that another outbreak will occur in the future defines an unmet medical need. Several promising drug candidate molecules have been reported via repurposing studies, high-throughput compound library screening, and de novo design in the short span of a few years. Intense research activity in this area has occurred in response to the World Health Organization declaration of a Public Health Emergency of International Concern on February 1, 2016. In this Perspective, the authors review the emergence of Zika virus, the biology of its replication, targets for therapeutic intervention, target product profile, and current drug development initiatives.
Collapse
Affiliation(s)
| | - Lana T Tran
- Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy , University of North Carolina at Chapel Hill , Chapel Hill , North Carolina 27599 , United States
| | | | - Yepeng Luan
- Department of Medicinal Chemistry, School of Pharmacy , Qingdao University , Qingdao 266071 , Shandong , China
| | | | - Rongshi Li
- Department of Medicinal Chemistry, School of Pharmacy , Qingdao University , Qingdao 266071 , Shandong , China.,UNMC Center for Drug Discovery, Department of Pharmaceutical Sciences, College of Pharmacy, Fred and Pamela Buffett Cancer Center, and Center for Staphylococcal Research , University of Nebraska Medical Center , Omaha , Nebraska 68198 , United States
| |
Collapse
|
7
|
Kumar TU, Thigulla Y, Rangan K, Bhattacharya A. Application of Polyphosphoric Acid‐Mediated Acyl Migration for Regiospecific Synthesis of Diverse 2‐Acylpyrroles from Chalcones. J Heterocycl Chem 2019. [DOI: 10.1002/jhet.3494] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- Togiti Uday Kumar
- Department of Chemistry Birla Institute of Technology and Science, Pilani (Hyderabad Campus) Hyderabad 500078 India
| | - Yadagiri Thigulla
- Department of Chemistry Birla Institute of Technology and Science, Pilani (Hyderabad Campus) Hyderabad 500078 India
| | - Krishnan Rangan
- Department of Chemistry Birla Institute of Technology and Science, Pilani (Hyderabad Campus) Hyderabad 500078 India
| | - Anupam Bhattacharya
- Department of Chemistry Birla Institute of Technology and Science, Pilani (Hyderabad Campus) Hyderabad 500078 India
| |
Collapse
|
8
|
Saha R, Perveen N, Nihesh N, Sekar G. Reusable Palladium Nanoparticles Catalyzed Oxime Ether Directed Mono
Ortho
‐Hydroxylation under Phosphine Free Neutral Condition. Adv Synth Catal 2018. [DOI: 10.1002/adsc.201801340] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Rajib Saha
- Department of ChemistryIndian Institute of Technology Madras Chennai- 600036 India
| | - Naziya Perveen
- Department of ChemistryIndian Institute of Technology Madras Chennai- 600036 India
| | - Naorem Nihesh
- Department of ChemistryIndian Institute of Technology Madras Chennai- 600036 India
| | - Govindasamy Sekar
- Department of ChemistryIndian Institute of Technology Madras Chennai- 600036 India
| |
Collapse
|
9
|
Kemung HM, Tan LTH, Khan TM, Chan KG, Pusparajah P, Goh BH, Lee LH. Streptomyces as a Prominent Resource of Future Anti-MRSA Drugs. Front Microbiol 2018; 9:2221. [PMID: 30319563 PMCID: PMC6165876 DOI: 10.3389/fmicb.2018.02221] [Citation(s) in RCA: 66] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2018] [Accepted: 08/30/2018] [Indexed: 01/21/2023] Open
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) pose a significant health threat as they tend to cause severe infections in vulnerable populations and are difficult to treat due to a limited range of effective antibiotics and also their ability to form biofilm. These organisms were once limited to hospital acquired infections but are now widely present in the community and even in animals. Furthermore, these organisms are constantly evolving to develop resistance to more antibiotics. This results in a need for new clinically useful antibiotics and one potential source are the Streptomyces which have already been the source of several anti-MRSA drugs including vancomycin. There remain large numbers of Streptomyces potentially undiscovered in underexplored regions such as mangrove, deserts, marine, and freshwater environments as well as endophytes. Organisms from these regions also face significant challenges to survival which often result in the production of novel bioactive compounds, several of which have already shown promise in drug development. We review the various mechanisms of antibiotic resistance in MRSA and all the known compounds isolated from Streptomyces with anti-MRSA activity with a focus on those from underexplored regions. The isolation of the full array of compounds Streptomyces are potentially capable of producing in the laboratory has proven a challenge, we also review techniques that have been used to overcome this obstacle including genetic cluster analysis. Additionally, we review the in vivo work done thus far with promising compounds of Streptomyces origin as well as the animal models that could be used for this work.
Collapse
Affiliation(s)
- Hefa Mangzira Kemung
- Novel Bacteria and Drug Discovery Research Group, Biomedicine Research Advancement Centre, School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia.,Biofunctional Molecule Exploratory Research Group, Biomedicine Research Advancement Centre, School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia
| | - Loh Teng-Hern Tan
- Novel Bacteria and Drug Discovery Research Group, Biomedicine Research Advancement Centre, School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia.,Biofunctional Molecule Exploratory Research Group, Biomedicine Research Advancement Centre, School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia.,Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia
| | - Tahir Mehmood Khan
- Novel Bacteria and Drug Discovery Research Group, Biomedicine Research Advancement Centre, School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia.,Biofunctional Molecule Exploratory Research Group, Biomedicine Research Advancement Centre, School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia.,The Institute of Pharmaceutical Sciences (IPS), University of Veterinary and Animal Sciences (UVAS), Lahore, Pakistan
| | - Kok-Gan Chan
- Division of Genetics and Molecular Biology, Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.,International Genome Centre, Jiangsu University, Zhenjiang, China
| | - Priyia Pusparajah
- Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia
| | - Bey-Hing Goh
- Novel Bacteria and Drug Discovery Research Group, Biomedicine Research Advancement Centre, School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia.,Biofunctional Molecule Exploratory Research Group, Biomedicine Research Advancement Centre, School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia.,Center of Health Outcomes Research and Therapeutic Safety (Cohorts), School of Pharmaceutical Sciences, University of Phayao, Mueang Phayao, Thailand
| | - Learn-Han Lee
- Novel Bacteria and Drug Discovery Research Group, Biomedicine Research Advancement Centre, School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia.,Biofunctional Molecule Exploratory Research Group, Biomedicine Research Advancement Centre, School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia.,Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia.,Center of Health Outcomes Research and Therapeutic Safety (Cohorts), School of Pharmaceutical Sciences, University of Phayao, Mueang Phayao, Thailand
| |
Collapse
|
10
|
Development and Validation of a Phenotypic High-Content Imaging Assay for Assessing the Antiviral Activity of Small-Molecule Inhibitors Targeting Zika Virus. Antimicrob Agents Chemother 2018; 62:AAC.00725-18. [PMID: 30061280 DOI: 10.1128/aac.00725-18] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2018] [Accepted: 05/30/2018] [Indexed: 02/07/2023] Open
Abstract
Zika virus (ZIKV) has been linked to the development of microcephaly in newborns, as well as Guillain-Barré syndrome. There are currently no drugs available to treat ZIKV infection, and accordingly, there is an unmet medical need for the discovery of new therapies. High-throughput drug screening efforts focusing on indirect readouts of cell viability are prone to a higher frequency of false positives in cases where the virus is viable in the cell but the cytopathic effect (CPE) is reduced or delayed. Here, we describe a fast and label-free phenotypic high-content imaging assay to detect cells affected by the virus-induced CPE using automated imaging and analysis. Protection from the CPE correlates with a decrease in viral antigen production, as observed by immunofluorescence. We trained our assay using a collection of nucleoside analogues with activity against ZIKV; the previously reported antiviral activities of 2'-C-methylribonucleosides and ribavirin against the Zika virus in Vero cells were confirmed using our developed method. To validate the ability of our assay to reveal new anti-ZIKV compounds, we profiled a novel library of 24 natural product derivatives and found compound 1 to be an inhibitor of the ZIKV-induced cytopathic effect; the activity of the compound was confirmed in human fetal neural stem cells (NSCs). The described technique can be easily leveraged as a primary screening assay for profiling of the activities of large compound libraries against ZIKV and can be expanded to other ZIKV strains and other cell lines displaying morphological changes upon ZIKV infection.
Collapse
|
11
|
Abstract
Synthetic methods inspired by Nature often offer unique advantages including mild conditions and biocompatibility with aqueous media. Inspired by an ergothioneine biosynthesis protein EgtB, a mononuclear non-haem iron enzyme capable of catalysing the C-S bond formation and sulfoxidation, herein, we discovered a mild and metal-free C-H sulfenylation/intramolecular rearrangement cascade reaction employing an internally oxidizing O-N bond as a directing group. Our strategy accommodates a variety of oxyamines with good site selectivity and intrinsic oxidative properties. Combining an O-N bond with an X-S bond generates a C-S bond and an S=N bond rapidly. The newly discovered cascade reaction showed excellent chemoselectivity and a wide substrate scope for both oxyamines and sulfenylation reagents. We demonstrated the biocompatibility of the C-S bond coupling reaction by applying a coumarin-based fluorogenic probe in bacterial lysates. Finally, the C-S bond coupling reaction enabled the first fluorogenic formation of phospholipids, which self-assembled to fluorescent vesicles in situ.
Collapse
|
12
|
Stodulski M, Kohlhepp SV, Raabe G, Gulder T. Exploration of the Bis(thio)urea-Catalyzed Atropselective Synthesis of Marinopyrrole A. European J Org Chem 2016. [DOI: 10.1002/ejoc.201600147] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
13
|
Liang YF, Wang X, Yuan Y, Liang Y, Li X, Jiao N. Ligand-Promoted Pd-Catalyzed Oxime Ether Directed C–H Hydroxylation of Arenes. ACS Catal 2015. [DOI: 10.1021/acscatal.5b01700] [Citation(s) in RCA: 86] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Affiliation(s)
- Yu-Feng Liang
- State
Key Laboratory of Natural and Biomimetic Drugs, Peking University,
School of Pharmaceutical Sciences, Peking University, Xue Yuan
Road 38, Beijing 100191, China
| | - Xiaoyang Wang
- State
Key Laboratory of Natural and Biomimetic Drugs, Peking University,
School of Pharmaceutical Sciences, Peking University, Xue Yuan
Road 38, Beijing 100191, China
| | - Yizhi Yuan
- State
Key Laboratory of Natural and Biomimetic Drugs, Peking University,
School of Pharmaceutical Sciences, Peking University, Xue Yuan
Road 38, Beijing 100191, China
| | - Yujie Liang
- State
Key Laboratory of Natural and Biomimetic Drugs, Peking University,
School of Pharmaceutical Sciences, Peking University, Xue Yuan
Road 38, Beijing 100191, China
| | - Xinyao Li
- State
Key Laboratory of Natural and Biomimetic Drugs, Peking University,
School of Pharmaceutical Sciences, Peking University, Xue Yuan
Road 38, Beijing 100191, China
| | - Ning Jiao
- State
Key Laboratory of Natural and Biomimetic Drugs, Peking University,
School of Pharmaceutical Sciences, Peking University, Xue Yuan
Road 38, Beijing 100191, China
- State
Key Laboratory of Organometallic Chemistry, Chinese Academy of Sciences, Shanghai 200032, China
| |
Collapse
|
14
|
Li R. Marinopyrroles: Unique Drug Discoveries Based on Marine Natural Products. Med Res Rev 2015; 36:169-89. [DOI: 10.1002/med.21359] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Affiliation(s)
- Rongshi Li
- Department of Pharmaceutical Sciences, Center for Drug Discovery; College of Pharmacy, Cancer Genes and Molecular Regulation Program, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center; Omaha NE 68198-6805
| |
Collapse
|
15
|
Gribble GW. Biological Activity of Recently Discovered Halogenated Marine Natural Products. Mar Drugs 2015; 13:4044-136. [PMID: 26133553 PMCID: PMC4515607 DOI: 10.3390/md13074044] [Citation(s) in RCA: 176] [Impact Index Per Article: 19.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2015] [Revised: 06/15/2015] [Accepted: 06/17/2015] [Indexed: 01/08/2023] Open
Abstract
This review presents the biological activity-antibacterial, antifungal, anti-parasitic, antiviral, antitumor, antiinflammatory, antioxidant, and enzymatic activity-of halogenated marine natural products discovered in the past five years. Newly discovered examples that do not report biological activity are not included.
Collapse
Affiliation(s)
- Gordon W Gribble
- Department of Chemistry, Dartmouth College, Hanover, NH 03755, USA.
| |
Collapse
|
16
|
Smyth JE, Butler NM, Keller PA. A twist of nature – the significance of atropisomers in biological systems. Nat Prod Rep 2015; 32:1562-83. [DOI: 10.1039/c4np00121d] [Citation(s) in RCA: 293] [Impact Index Per Article: 32.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
This review encompasses the synthesis and identification of recently detected natural atropisomers with potential therapeutic activity.
Collapse
Affiliation(s)
- Jamie E. Smyth
- School of Chemistry
- University of Wollongong
- Wollongong
- Australia 2522
| | | | - Paul A. Keller
- School of Chemistry
- University of Wollongong
- Wollongong
- Australia 2522
| |
Collapse
|
17
|
Li R, Cheng C, Balasis ME, Liu Y, Garner TP, Daniel KG, Li J, Qin Y, Gavathiotis E, Sebti SM. Design, synthesis and evaluation of marinopyrrole derivatives as selective inhibitors of Mcl-1 binding to pro-apoptotic Bim and dual Mcl-1/Bcl-xL inhibitors. Eur J Med Chem 2014; 90:315-331. [PMID: 25437618 DOI: 10.1016/j.ejmech.2014.11.035] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2014] [Revised: 10/20/2014] [Accepted: 11/19/2014] [Indexed: 12/22/2022]
Abstract
Inhibition of anti-apoptotic Mcl-1 is a promising anticancer strategy to overcome the survival and chemoresistance of a broad spectrum of human cancers. We previously reported on the identification of a natural product marinopyrrole A (1) that induces apoptosis in Mcl-1-dependent cells through Mcl-1 degradation. Here, we report the design and synthesis of novel marinopyrrole-based analogs and their evaluation as selective inhibitors of Mcl-1 as well as dual Mcl-1/Bcl-xL inhibitors. The most selective Mcl-1 antagonists were 34, 36 and 37 with 16-, 13- and 9-fold more selectivity for disrupting Mcl-1/Bim over Bcl-xL/Bim binding, respectively. Among the most potent dual inhibitors is 42 which inhibited Mcl-1/Bim and Bcl-xL/Bim binding 15-fold (IC50 = 600 nM) and 33-fold (500 nM) more potently than (±)-marinopyrrole A (1), respectively. Fluorescence quenching, NMR analysis and molecular docking indicated binding of marinopyrroles to the BH3 binding site of Mcl-1. Several marinopyrroles potently decreased Mcl-1 cellular levels and induced caspase 3 activation in human breast cancer cells. Our studies provide novel "lead" marinopyrroles for further optimization as selective Mcl-1 inhibitors and dual Mcl-1 and Bcl-xL inhibitors.
Collapse
Affiliation(s)
- Rongshi Li
- Department of Pharmaceutical Sciences, Center for Drug Discovery, College of Pharmacy, Cancer Genes and Molecular Regulation Program, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, 986805 Nebraska Medical Center, Omaha, NE 68198, United States
- Department of Drug Discovery, Chemical Biology & Molecular Medicine Program, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, United States
- Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs, Tampa, FL 33612, United States
| | - Chunwei Cheng
- Key Laboratory of Drug Targeting and Drug Delivery Systems of the Ministry of Education, West China School of Pharmacy, and State Key Laboratory of Biotherapy, Sichuan University, Chengdu 610041, China
| | - Maria E Balasis
- Department of Drug Discovery, Chemical Biology & Molecular Medicine Program, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, United States
| | - Yan Liu
- Department of Pharmaceutical Sciences, Center for Drug Discovery, College of Pharmacy, Cancer Genes and Molecular Regulation Program, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, 986805 Nebraska Medical Center, Omaha, NE 68198, United States
| | - Thomas P Garner
- Departments of Biochemistry and Medicine, Albert Einstein Cancer Center, Albert Einstein College of Medicine, Jack and Pearl Resnick Campus, 1300 Morris Park Avenue, Forchheimer G46, Bronx, NY 10461, United States
| | - Kenyon G Daniel
- Department of Drug Discovery, Chemical Biology & Molecular Medicine Program, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, United States
| | - Jerry Li
- Department of Drug Discovery, Chemical Biology & Molecular Medicine Program, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, United States
| | - Yong Qin
- Key Laboratory of Drug Targeting and Drug Delivery Systems of the Ministry of Education, West China School of Pharmacy, and State Key Laboratory of Biotherapy, Sichuan University, Chengdu 610041, China
| | - Evripidis Gavathiotis
- Departments of Biochemistry and Medicine, Albert Einstein Cancer Center, Albert Einstein College of Medicine, Jack and Pearl Resnick Campus, 1300 Morris Park Avenue, Forchheimer G46, Bronx, NY 10461, United States
| | - Said M Sebti
- Department of Drug Discovery, Chemical Biology & Molecular Medicine Program, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, United States
- Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs, Tampa, FL 33612, United States
| |
Collapse
|
18
|
Jafarpour F, Hazrati H, Darvishmolla M. Acylation of Pyrroles and their Free (N-H)-DerivativesviaPalladium-Catalyzed Carbopalladation of Nitriles. Adv Synth Catal 2014. [DOI: 10.1002/adsc.201400598] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
19
|
Marinopyrrole derivatives with sulfide spacers as selective disruptors of Mcl-1 binding to pro-apoptotic protein Bim. Mar Drugs 2014; 12:4311-25. [PMID: 25076060 PMCID: PMC4145318 DOI: 10.3390/md12084311] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2014] [Revised: 05/23/2014] [Accepted: 07/14/2014] [Indexed: 01/23/2023] Open
Abstract
A series of novel marinopyrroles with sulfide and sulphone spacers were designed and synthesized. Their activity to disrupt the binding of the pro-apoptotic protein, Bim, to the pro-survival proteins, Mcl-1 and Bcl-xL, was evaluated using ELISA assays. Fluorescence-quenching (FQ) assays confirmed the direct binding of marinopyrroles to Mcl-1. Benzyl- and benzyl methoxy-containing sulfide derivatives 4 and 5 were highly potent dual Mcl-1/Bim and Bcl-xL/Bim disruptors (IC50 values of 600 and 700 nM), whereas carboxylate-containing sulfide derivative 9 exhibited 16.4-fold more selectivity for disrupting Mcl-1/Bim over Bcl-xL/Bim binding. In addition, a nonsymmetrical marinopyrrole 12 is as equally potent as the parent marinopyrrole A (1) for disrupting both Mcl-1/Bim and Bcl-xL/Bim binding. Some of the derivatives were also active in intact human breast cancer cells where they reduced the levels of Mcl-1, induced programd cell death (apoptosis) and inhibited cell proliferation.
Collapse
|
20
|
Marinopyrrole derivatives as potential antibiotic agents against methicillin-resistant Staphylococcus aureus (III). Mar Drugs 2014; 12:2458-70. [PMID: 24796304 PMCID: PMC4052300 DOI: 10.3390/md12052458] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2014] [Revised: 03/21/2014] [Accepted: 03/24/2014] [Indexed: 12/25/2022] Open
Abstract
The marine natural product, marinopyrrole A (1), was previously shown to have significant antibiotic activity against Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). Although compound (1) exhibits a significant reduction in MRSA activity in the presence of human serum, we have identified key modifications that partially restore activity. We previously reported our discovery of a chloro-derivative of marinopyrrole A (1a) featuring a 2–4 fold improved minimum inhibitory concentration (MIC) against MRSA, significantly less susceptibility to serum inhibition and rapid and concentration-dependent killing of MRSA. Here, we report a novel fluoro-derivative of marinopyrrole A (1e) showing an improved profile of potency, less susceptibility to serum inhibition, as well as rapid and concentration-dependent killing of MRSA.
Collapse
|
21
|
Cheng C, Liu Y, Balasis ME, Simmons NL, Li J, Song H, Pan L, Qin Y, Nicolaou KC, Sebti SM, Li R. Cyclic marinopyrrole derivatives as disruptors of Mcl-1 and Bcl-x(L) binding to Bim. Mar Drugs 2014; 12:1335-48. [PMID: 24608970 PMCID: PMC3967213 DOI: 10.3390/md12031335] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2013] [Revised: 02/17/2014] [Accepted: 02/18/2014] [Indexed: 11/16/2022] Open
Abstract
A series of novel cyclic marinopyrroles were designed and synthesized. Their activity to disrupt the binding of the pro-apoptotic protein, Bim, to the pro-survival proteins, Mcl-1 and Bcl-x(L), was evaluated using ELISA assays. Both atropisomers of marinopyrrole A (1) show similar potency. A tetrabromo congener 9 is two-fold more potent than 1. Two novel cyclic marinopyrroles (3 and 4) are two- to seven-fold more potent than 1.
Collapse
Affiliation(s)
- Chunwei Cheng
- Key Laboratory of Drug Targeting and Drug Delivery Systems of the Ministry of Education and State Key Laboratory of Biotherapy, Department of Medicinal Natural Products, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
| | - Yan Liu
- Chemical Biology & Molecular Medicine Program, Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.
| | - Maria E Balasis
- Chemical Biology & Molecular Medicine Program, Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.
| | - Nicholas L Simmons
- Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
| | - Jerry Li
- Chemical Biology & Molecular Medicine Program, Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.
| | - Hao Song
- Key Laboratory of Drug Targeting and Drug Delivery Systems of the Ministry of Education and State Key Laboratory of Biotherapy, Department of Medicinal Natural Products, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
| | - Lili Pan
- Key Laboratory of Drug Targeting and Drug Delivery Systems of the Ministry of Education and State Key Laboratory of Biotherapy, Department of Medicinal Natural Products, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
| | - Yong Qin
- Key Laboratory of Drug Targeting and Drug Delivery Systems of the Ministry of Education and State Key Laboratory of Biotherapy, Department of Medicinal Natural Products, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
| | - K C Nicolaou
- Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
| | - Said M Sebti
- Chemical Biology & Molecular Medicine Program, Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.
| | - Rongshi Li
- Chemical Biology & Molecular Medicine Program, Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.
| |
Collapse
|